Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Early α-synuclein-mediated mitochondrial dysfunction in a human cell model of Parkinson's disease dementia.

Communications biology·2026
Same author

ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression.

Nature·2026
Same author

Childhood brain tumors instruct cranial hematopoiesis and immunotolerance.

Nature genetics·2026
Same author

Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.

Nature genetics·2025
Same author

Retraction Note: Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.

Nature·2025
Same author

Gene context drift identifies drug targets to mitigate cancer treatment resistance.

Cancer cell·2025
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
Same journal

Systematic discovery of pathogen effector functions across human pathogens and pathways.

Cell·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jun 3, 2026

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion
05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

Mapear los orígenes del cáncer.

Richard J Gilbertson1

  • 1Department of Developmental Neurobiology and Oncology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA. richard.gilbertson@stjude.org

Cell
|April 5, 2011
PubMed
Resumen
Este resumen es generado por máquina.

El cáncer es una enfermedad diversa que mata a millones de personas anualmente. La integración de tecnologías genómicas y de células madre ofrece un nuevo enfoque prometedor para desarrollar curas para todos los pacientes con cáncer.

Más Videos Relacionados

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Videos de Experimentos Relacionados

Last Updated: Jun 3, 2026

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion
05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Área de la Ciencia:

  • Oncología Oncología.
  • La genómica es la genómica.
  • Biología de las células madre Biología de las células madre

Sus antecedentes:

  • El cáncer representa un grupo complejo de más de 200 enfermedades con una mortalidad global significativa.
  • Las estrategias terapéuticas actuales se ven obstaculizadas por la falta de una comprensión integral de la heterogeneidad del cáncer.

Objetivo del estudio:

  • Explorar el potencial de la integración de tecnologías genómicas y de células madre para superar los desafíos en la investigación del cáncer.
  • Identificar nuevas vías terapéuticas para diversos tipos de cáncer.

Principales métodos:

  • Revisión y síntesis de los avances recientes en la genómica del cáncer.
  • Análisis de enfoques terapéuticos basados en células madre en entornos preclínicos y clínicos.
  • Integración de datos multi-ómicos con los principios de la biología de las células madre.

Principales resultados:

  • Los perfiles genómicos revelan conocimientos críticos sobre las mutaciones y vías de conducción del cáncer.
  • Las tecnologías de células madre ofrecen potencial para la administración de fármacos dirigidos y la medicina regenerativa en el cáncer.
  • Los enfoques combinados de genómica y células madre son prometedores en el modelado y tratamiento de cánceres complejos.

Conclusiones:

  • La convergencia de la genómica y las tecnologías de células madre presenta una poderosa estrategia para abordar la diversidad del cáncer.
  • Este enfoque integrado es crucial para avanzar en la medicina de precisión y lograr una cura para cada paciente.
  • Se justifica una mayor investigación para traducir completamente estas tecnologías integradas en la práctica clínica.